title: [Effect of losartan on sarcoplasmic reticulum Ca2+ handing proteins in heart failure rabbit].
abstract: OBJECTIVE
  To investigate the effects of losartan on mRNA expression of myocardial sarcoplasmic reticulum calcium handling proteins (SERCA2, RyR2 and PLB) and the role of which in prevention of chronic heart failure in rabbit.
  
  
  METHODS
  After chronic heart failure was induced by ligation of the left anterior descending artery in rabbits, the animals were treated with losartan. At 8 weeks after ligation, left ventricular function, hemodynamic parameters, and SERCA2, RyR2, PLB mRNA expressions were observed.
  
  
  RESULTS
  Compared with the control group (group C), LVEDP in the infarcted group (group I) increased (P < 0.01), while +dp/dt(max) and -dp/dt(max) decreased significantly (P < 0.01). LVEDP was lower but +dp/dt(max) and -dp/dt(max) significantly higher in the losartan treated group (group L) than those in group I (P < 0.05). SERCA2, RyR2, and PLB mRNA expressions in group I were remarkably lower than those in group L (P < 0.01) and group C (P < 0.01), respectively.
  
  
  CONCLUSIONS
  Losartan can improve cardiac function, probably owing to its upregulating mRNA expressions of myocardial sarcoplasmic reticulum Ca(2+) handling proteins (RyR2, SERCA2 and PLB) in the prevention of heart failure.
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Yao
authors.forename: Cong-xin
authors.initials: CX
authors.lastname: Huang
authors.forename: Gao
authors.initials: G
authors.lastname: Chen
authors.forename: Lin
authors.initials: L
authors.lastname: Xu
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000187:drug effects; D002147:Calmodulin / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D019808:Losartan / Q000494:pharmacology*; D008297:Male; D011817:Rabbits; D019837:Ryanodine Receptor Calcium Release Channel / Q000096:biosynthesis*; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D015220:Calcium Channels; D002147:Calmodulin; D019837:Ryanodine Receptor Calcium Release Channel; D019808:Losartan; D002118:Calcium